Patient group
Erwachsene mit generalisierter Myasthenia gravis, die Anti-Acetylcholin-Rezeptor -Antikörper positiv sind
final resolution2023-02-16repealed
Arzneimittel-Richtlinie/Anlage XII: Efgartigimod alfa (Myasthenia gravis, AChR-Antikörper+)
Open official decision page ↗
G-BA source · retrieved 2026-08-05
Structured conclusion
Final result by patient group
1 source-verified result
Decision orientation
What the G-BA did
4 cited claims
Each claim links to the official G-BA page or an exact PDF page range.
Official metadata
- Decision date
- 2023-02-16
- Effective
- aufgehoben
- Action type
- final resolution
- Committee
- Arzneimittel
Case context
Listed normative targets
directiveArzneimittel-Richtlinie
directive annexAnlage XII: Nutzenbewertung nach § 35a SGB V
A listed target is not treated as a new directive version unless an official version source exists.
Official document package